One possible explanation could be that MYBL2 and FOXM1 might influence cancer cell survival through mechanisms other than cell cycle regulation, such as apoptosis or metabolic adaptation, which are critical for sustaining the growth and survival of metastatic cancer cells. Here, MYBL2 is linked to metastatic malignant neoplasm.